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Results: Aggrecan degradation and its inhibition demonstrated
cross-correlation between bovine articular cartilage explants as-
sayed via DMMB proteoglycan assay and IA/LC/MS/MS assays.
Dose-dependent reduction of the ARGS biomarker was also
demonstrated in human articular cartilage explants. The ARGS
biomarker was further detected in human urine analyzed by
IA/LC/MS/MS with a high degree of variability between patients.
Due to the development of an improved ARGS neoepitope an-
tibody, an BC3-C2/HABR ELISA was utilized to analysis human
articular cartilage explant samples and clinical patient urine sam-
ples. Approximately 500 pg/mL biomarker values were detected
in the ELISA, agreeing with data obtained from the IA/LC/MS/MS
data and literature reports.
Conclusions: The ARGSVIL peptide demonstrates high potential
as a drug activity biomarker of aggrecan degradation. Current
results validate its presence in human urine and demonstrate dose
response reduction with aggrecanase inhibition. This biomarker
promises to speed dose selection and predict target inhibition in
human clinical studies of aggrecanase inhibitors.
129
DIURNAL VARIATION OF AMINO ACIDS AND
ACYLCARNITINES IN A COHORT WITH KNEE OA
D.K. Thompson, V.B. Kraus, R.J. Sloane
Duke Univ., Durham, NC
Purpose: Biomarker levels can ﬂuctuate in response to daily
activity, including feeding. In order to ascertain the degree and
direction of these changes, and in anticipation of investigating the
interaction of these agents with OA, markers of energy metabolism
were measured at various time points, including before and after
a mixed-nutrient meal.
Methods: 40 subjects with radiographic OA of at least one knee
were admitted overnight to the General Clinical Research Center
of Duke University to undergo serial serum sampling. Blood was
collected in the evening (T=3, 6-8pm, n=40), before rising from
bed or eating (T=0, 8am, n=40), 1 hour after rising but before
eating (T=1A, 9 am, n=20), 1-2 hours after rising and breakfast
(T=1, 9-10 am, n=40), and at noon (T=2, n=20). Breakfast included
protein, carbohydrate, and fat. Quantitative mass spectrometry of
15 amino acids (AAs), and 45 acyl carnitines (ACs), was performed
by stable-isotope dilution. The mean of the values for each time
point was normalized to the mean at baseline (T=0). Values for
acyl carnitines were log-transformed.
Results: All 15 amino acids displayed signiﬁcant (p<0.05)
changes between baseline and various time points ranging from 4-
43% (Table 1). The most notable increase occurred after consump-
tion of a mixed meal, when 14 AAs increased 7-23%. Statistically
signiﬁcant increases continued throughout the day for most AAs in
a monotonic pattern. Histidine showed the greatest stability, with
a statistically signiﬁcant change occurring only at T3 compared
to baseline (T0). Alanine, proline, valine, leucine/isoleucine, me-
thionine, phenylalanine, tyrosine, Aspartate/asparagine, ornithine,
and arginine varied signiﬁcantly in at least three of three of the
timepoints relative to baseline.
All 45 acylcarnitines (ACs) displayed statistically signiﬁcant
changes at various time points as compared to baseline (15
representative ACs shown in Table 2). Unlike AAs, which generally
displayed the same monotonic pattern to varying degrees, the
ACs varied widely in their diurnal proﬁles. The ACs also gener-
ally displayed smaller increases (typically 1-10%) as compared to
AAs (4-43%). Similar to AAs, an increase in serum concentration
was most common after ingestion of a mixed meal, as 31 ACs
displayed statistically signiﬁcant increases in the range of 1-16%.
Conclusions: From this preliminary study it is evident that major
classes of energy metabolites, including amino acids and acyl
carnitines, vary signiﬁcantly in response to normal daily activi-
ties including food intake. Elucidating these diurnal variations in
metabolites is an important early step in understanding the greater
complexities of energy balance. Furthermore, we hypothesize that
many of the agents of energy balance are intricately involved with
biomarkers of osteoarthritis, and deﬁning underlying metabolic
proﬁles will promote a more complete understanding of health
and disease states. Finally, of signiﬁcant practical importance, this
study underscores the need for researchers to plan deliberately
and act consistently when collecting samples for biomarker mea-
surement, since inconsistent sampling could introduce spurious
variations in the data.
130
CYTOKINE-INDUCED AGGRECANASE- AND MMP-DERIVED
RELEASE OF AGGRECAN FRAGMENTS INTO THE
SUPERNATANTS OF HUMAN OA ARTICULAR CARTILAGE
CULTURES; DIFFERENCES TO CORRESPONDING
PROFILES ORIGINATING FROM BOVINE CULTURES
P. Chen1, B. Wang2, A.C. Bay-Jensen3, M. Karsdal3,
S.H. Madsen3, Q. Zheng3, P. Qvist3
1Nordic BioSci., Beijing, China; 2Nordic BioSci., Beijing, Denmark;
3Nordic BioSci., Herlev, Denmark
Purpose: Quantitative measurement of aggrecan fragments re-
leased from explants cultures is a validated model for the study
of metabolic processes relevant during cartilage degradation. We
wanted to investigate, if a new series of neo-epitope speciﬁc im-
munoassays could be applied in the proﬁling of aggrecanase-
and MMP-derived aggrecan fragments released into the super-
natant of articular cartilage explants originating from patients with
osteoarthritis.
